KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) Shares Outstanding (Diluted Average) (2016 - 2022)

Sabra Health Care REIT has reported Shares Outstanding (Diluted Average) over the past 13 years, most recently at $231.6 million for Q1 2022.

  • For Q1 2022, Shares Outstanding (Diluted Average) rose 8.91% year-over-year to $231.6 million; the TTM value through Mar 2022 reached $231.6 million, up 8.91%, while the annual FY2021 figure was $219.1 million, 5.7% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2022 was $231.6 million at Sabra Health Care REIT, up from $219.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $231.6 million in Q1 2022 and troughed at $178.4 million in Q1 2019.
  • A 5-year average of $198.8 million and a median of $206.1 million in 2020 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 172.09% in 2018 and later decreased 0.07% in 2019.
  • Year by year, Shares Outstanding (Diluted Average) stood at $178.7 million in 2018, then rose by 3.34% to $184.7 million in 2019, then grew by 12.21% to $207.3 million in 2020, then increased by 5.7% to $219.1 million in 2021, then rose by 5.7% to $231.6 million in 2022.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SBRA at $231.6 million in Q1 2022, $219.1 million in Q4 2021, and $216.2 million in Q3 2021.